The effect of proton pump inhibitor uses on outcomes for cancer patients treated with immune checkpoint inhibitors: a meta-analysis

BACKGROUND: Proton pump inhibitors (PPIs) are commonly prescribed for preventing and treating gastrointestinal ulcers. In patients with advanced cancer, it is unclear whether concomitant use of immune checkpoint inhibitors (ICIs) and PPIs could result in poorer outcomes. This study investigates the...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Chao, Xia, Zhengzheng, Li, Anna, Meng, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812177/
https://www.ncbi.nlm.nih.gov/pubmed/33490167
http://dx.doi.org/10.21037/atm-20-7498

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812177/
https://www.ncbi.nlm.nih.gov/pubmed/33490167
http://dx.doi.org/10.21037/atm-20-7498

Ejemplares similares